Delivery Order SPE2DR25D1106-SPE2DR26FJD7X
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% cream in a 30-gram formulation, valued at $3,306.91 with a firm fixed price arrangement. This contract, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a non-set-aside competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,741.30 to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% cream in 30-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,545.65 to AmerisourceBergen Drug Corp for the supply of Hydrocort-Pramoxine 1%-1% cream in 30-gram quantities. This contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency awarded a $3,778.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream (28.4 grams) on August 27, 2025, with completion targeted for August 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not set-aside and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $1,393.35 to AmerisourceBergen Drug Corp for Hydrocortisone-Pramoxine 2.5-1% cream in a 28.4-gram unit on October 30, 2025, with completion due by October 31, 2025. This is a firm fixed price delivery order with no set-aside designation, placed against a larger indefinite delivery contract. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,322.49 to AmerisourceBergen Drug Corp for Hydrocortisone-Pramoxine 2.5-1% cream in 30-gram quantities. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 16, 2025. The award was issued on December 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Hydrocortisone 1% Cream in 30-gram units, with a ceiling value of $3,398.24. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support...
- This is a delivery order issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with AmerisourceBergen Drug Corporation to supply a pharmaceutical product - Hydrocort-Pramoxine 1%-1% Cream in 30-gram tubes. The delivery order has a ceiling value of $1,820.31 and a completion date of September 12, 2024. The contract is a firm-fixed-price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as well as multiple...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.71 firm fixed-price contract is for the supply of Hydrocort-Pramoxine 1%-1% cream, a topical pharmaceutical product, with a completion date of January 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD7XDelivery Order
The Defense Logistics Agency awarded a $1,569.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Hydrocort-Pramoxine 1%-1% cream in a 30-gram unit. This non-set-aside contract represents a straightforward medical commodity procurement with performance scheduled for completion by December 16, 2025, at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through competitive awards across the Defense Health Agency and other government healthcare systems. This particular order for topical corticosteroid-anesthetic cream is consistent with the company's extensive portfolio of pharmaceutical deliveries under its DLA prime vendor contract, which encompasses specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains in support of military operations and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/14/25 |